February saw significant merger and acquisition activity involving Boston-based firms and major players in the pharmaceutical sector. According to recent reports, two Boston community solar companies completed a merger, highlighting ongoing consolidation in the region’s clean energy sector. In addition to local developments, global pharmaceutical companies GSK and Eli Lilly executed major biotech acquisitions during…
